G08520NM

Summary
GlyTouCan ID
G08520NM
IUPAC Condensed
GlcNAc(b1-2)Man(a1-3)[Man(a1-3)[Man(a1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc(b1-
Motifs
N-Glycan hybrid
Subsumption Level
Fully-defined saccharide
Monoisotopic Mass
1437.51
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
GlycoShape
Displaying 1 entry
Archetype α β
G78341DP
G01999JH
G08520NM
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT1 UDP-GlcNAc
G55220VL
Asn-X
G08520NM
Asn-X
Displaying 1 entry
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
MGAT1 UDP-GlcNAc
G55220VL
Asn-X
G08520NM
Asn-X
KEGG BRITE Database
KEGG ID
Enzyme
Reactions
Displaying all 2 entries
KEGG Reaction Enzyme Acceptor Product
R05984
R05983
GALAXY
Glucose Units
ODS
7.3
Amide
6.5
Degrading Enzymes
Displaying all 5 entries
Enzyme Substrate Product
α-Fucosidase
G50730KL
G08520NM
α-Fucosidase
G82942ZJ
G08520NM
β-Galactosidase
G16828VN
G08520NM
β-HexNAcase
G08520NM
G55220VL
β-Xylosidase
G13598WY
G08520NM
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
3b:b-dglc-HEX-1:5
4s:n-acetyl
5b:b-dman-HEX-1:5
6b:a-dman-HEX-1:5
7b:b-dglc-HEX-1:5
8s:n-acetyl
9b:a-dman-HEX-1:5
10b:a-dman-HEX-1:5
11b:a-dman-HEX-1:5
LIN
1:1d(2+1)2n
2:1o(4+1)3d
3:3d(2+1)4n
4:3o(4+1)5d
5:5o(3+1)6d
6:6o(2+1)7d
7:7d(2+1)8n
8:5o(6+1)9d
9:9o(3+1)10d
10:9o(6+1)11d
WURCS
WURCS=2.0/3,8,7/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5]/1-1-2-3-1-3-3-3/a4-b1_b4-c1_c3-d1_c6-f1_d2-e1_f3-g1_f6-h1
Literature
Displaying entries 1 - 10 of 13 in total
PubMed ID Title First Author Publication Date Source
33139572 Spatial and temporal diversity of glycome expression in mammalian brain Lee Jua 2020-11-17
  • GlyGen
32643525 Malignant tissues produce divergent antibody glycosylation of relevance for cancer gene therapy effectiveness Brücher Dominik 2020
  • GlyGen
25802287 A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM) Pabst M 2015 Jun
  • GlyGen
  • PubChem
26510530 A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins Hong Q 2015 Dec 4
  • GlyGen
  • PubChem
24706782 Expression and glycoengineering of functionally active heteromultimeric IgM in plants Loos A 2014 Apr 29
  • GlyGen
  • PubChem
24090084 Site-Specific Glycan-Peptide Analysis for Determination of N-Glycoproteome Heterogeneity Parker BL 2013 Dec 6
  • GlyGen
  • PubChem
20131323 Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry Ritchie G 2010 Feb 03
  • GlyGen
11469797 The widespread effect of beta 1,4-galactosyltransferase on N-glycan processing Fukuta K 2001 Aug 01
  • GlyGen
  • PubChem
10833030 Composition of N-linked carbohydrates from ovalbumin and co-purified glycoproteins Harvey DJ 2000 Jun
  • GlyGen
  • PubChem
10207177 Oligosaccharide analysis and molecular modeling of soluble forms of glycoproteins belonging to the Ly-6, scavenger receptor, and immunoglobulin superfamilies expressed in Chinese hamster ovary cells Rudd PM 1999 May
  • GlyGen
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025